Skip to main content

Want a detailed portfolio tracker?

Comparison Coeptis Therapeutics Holdings Inc. Common Stock (COEP) with Competitors

Coeptis Therapeutics Holdings Inc. Common Stock (COEP) industry is Biotechnology.

Debt-to-Equity
COEP0.87%
Industry28.27%
Upside-96.91%
Free Cash Flow Yield
COEP-36.42%
Industry-1.75%
Upside-34.67%
P/E
COEP-1.38
Industry-20.52
Upside+1914.18%